James P. Mackin

Biography

 Mr. Pat Mackin is a recognized and highly respected professional with more than 23 years of medical device industry experience. Mr. Mackin is President and CEO of CryoLife, Inc., a leading medical device and tissue processing company focused on cardiac and vascular surgery. He was appointed President and CEO in September 2014 and Chairman of the Board in April 2015. Prior to his appointment, Mr. Mackin served as President of Cardiac Rhythm Disease Management from 2007 to 2014, Medtronic’s largest operating division. In that role, he was responsible for the overall strategic direction of the $5 billion CRDM business and its day to day operations. Previously, he held several senior level positions including Vice President, Vascular, Western Europe from 2004 to 2007, where he successfully managed the international launch of the companies first drug eluting stent - Endeavor and Vice President & General Manager, Endovascular Business Unit from 2002 to 2004. Prior to joining Medtronic in 2002, Mr. Mackin worked for six years at Genzyme, Inc. serving as its Senior Vice President & General Manager for the Cardiovascular Surgery Business Unit and, earlier, as Director of Sales, Surgical Products division. Previously, he worked in various sales and marketing management roles at Deknatel/Snowden-Pencer from 1991 – 1996. Mr. Mackin also served in the United States Army as an Officer from 1988 to 1991. Mr. Mackin has a Master’s in Business Administration from Northwestern University’s Kellogg Graduate School of Management and is a graduate of the United States Military Academy at West Point.

Research Interest

 Endovascular Business